Management of Obesity as a Chronic Disease: Nonpharmacologic, Pharmacologic, and Surgical Options
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
The successful management of obesity requires a long‐term approach that is tailored to an individual's lifestyle and needs. Initial treatment should focus on lifestyle modifications—dietary interventions and increased physical activity—with behavioral modification strategies used adjunctively. Several antiobesity drugs are approved by the Food and Drug Administration for use in obese patients, as well as in overweight individuals with at least one obesity‐related comorbidity. Most are approved only for short‐term weight loss, but sibutramine and orlistat are approved for long‐term weight loss and maintenance. In addition to weight reduction, in clinical trials these drugs provided beneficial actions on several cardiovascular risk factors. Several other drugs currently approved for other uses show promise in their ability to cause weight loss. Surgical options should be reserved for severely obese patients with significant medical comorbidities or physical conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Gastrointestinal Surgery for Severe Obesity
Panel, C. D. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-12-956 · Cited by 2,163
Effect of sibutramine on weight maintenance after weight loss: a randomised trial
James, W. P. T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rössner, S., Saris, W. H. M., & Gaal, L. F. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03491-7 · Cited by 817
Hollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1288 · Cited by 654
Freedman, M. R., King, J., & Kennedy, E. (2001) · Obesity Research · doi:10.1038/oby.2001.113 · Cited by 421
Orlistat in the long-term treatment of obesity in primary care settings.
Hauptman, J. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.2.160 · Cited by 367
Bupropion SR Enhances Weight Loss: A 48‐Week Double‐Blind, Placebo‐ Controlled Trial
Anderson, J. W., Greenway, F. L., Fujioka, K., Gadde, K. M., McKenney, J., & O'Neil, P. M. (2002) · Obesity Research · doi:10.1038/oby.2002.86 · Cited by 315
Self-citationSt. Jeor, S. T., Howard, B. V., Prewitt, T. E., Bovee, V., Bazzarre, T., Eckel, R. H., & for the AHA Nutrition Committee (2001) · Circulation · doi:10.1161/hc4001.096152 · Cited by 292
Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
Hill, J. O., Hauptman, J., Anderson, J. W., Fujioka, K., O'Neil, P. M., Smith, D. K., Zavoral, J. H., & Aronne, L. J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1108 · Cited by 287
Self-citationEXERCISE IN WEIGHT MANAGEMENT OF OBESITY
Poirier, P., & Després, J.-P. (2001) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70229-0 · Cited by 272
Cited by
Beta Glucan: Health Benefits in Obesity and Metabolic Syndrome
El Khoury, D., Cuda, C., Luhovyy, B. L., & Anderson, G. H. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/851362 · Cited by 538
Weight loss during the intensive intervention phase of the weight-loss maintenance trial
Hollis, J. F., Gullion, C. M., Stevens, V. J., Brantley, P. J., Appel, L. J., Ard, J. D., Champagne, C. M., Dalcin, A., Erlinger, T. P., Funk, K., et al. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.04.013 · Cited by 321
TOS Obesity as a Disease Writing Group, Allison, D. B., Downey, M., Atkinson, R. L., Billington, C. J., Bray, G. A., Eckel, R. H., Finkelstein, E. A., Jensen, M. D., & Tremblay, A. (2008) · Obesity · doi:10.1038/oby.2008.231 · Cited by 321
Bult, M. J. F., van Dalen, T., & Muller, A. F. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0145 · Cited by 301
Pre‐ and Postsurgery Behavioral Compliance, Patient Health, and Postbariatric Surgical Weight Loss
Toussi, R., Fujioka, K., & Coleman, K. J. (2009) · Obesity · doi:10.1038/oby.2008.628 · Cited by 196
“This failure has lead to pharmacological approaches to weight loss; however, these too have had little success in maintenance of long-term weight loss (8,9).”
BackgroundMethodSelf-citation
Metadata
- Authors
- Fujioka, K.
- Venue
- Obesity Research
- Publisher
- Wiley
- Published
- 2002-12
- Volume
- 10
- Issue
- S12
- Pages
- 116S-123S
- ISSN
- 1071-7323 (ISSN-L)
- 1550-8528
- OpenAlex
- W2087880294
- Cited by
- 146
- References
- 15
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of Obesity as a Chronic Disease: Nonpharmacologic, Pharmacologic, and Surgical Options. https://app.cochat.ai/papers/10.1038/oby.2002.204
- The paper
- Fujioka, K. (2002). Management of Obesity as a Chronic Disease: Nonpharmacologic, Pharmacologic, and Surgical Options. Obesity Research. https://doi.org/10.1038/oby.2002.204
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.